Invesco

Flow Carbon uses blockchain technology to put carbon offset credits on-chain, accelerating the creativity and scalability of climate change solutions. Flow Carbon is headquartered in New York, United States and was founded in 2021.

GeNeuro is a biotechnology company that develops therapeutic drugs for diseases associated with the expression of pathogenic proteins of the human endogenous retroviral origin. The company is primarily focused on nervous system diseases such as multiple sclerosis and schizophrenia. Its products include GNbAC1, a therapeutic monoclonal antibody for the treatment of multiple sclerosis. It also develops diagnostic tests to dose the multiple sclerosis-associated retrovirus-ENV proteins in patients.GeNeuro was founded in 2006 and is based in Plan-Les-Ouates, Switzerland.

Swiggy designs an on-demand food delivery platform that brings food from neighborhood restaurants directly to users' doors. The company's food delivery platform lists local restaurants and menu lists on an app for users to order from and track delivery of its delivery executives, enabling users to order food with speed and convenience. Its service is used to pick up and drop off a diverse array of items, including laundry and document or parcel deliveries to business clients and retail customers. Swiggy was founded by Sriharsha Majety, Nandan Reddy, and Rahul Jaiminiin in 2014 and is headquartered in Bangalore, Karnataka, India.

Hum Capital is the funding platform that connects great companies with the right capital. Hum offers companies raising up to $50 million the most efficient, transparent path to growth. Hum’s Intelligent Capital Market uses AI to translate volumes of a company’s financial data into the clearest picture of their value, so they can fundraise with confidence, on the best terms for their business. Investors on Hum’s platform gain investment insights and a personalized deal flow built on company data they can trust. For more information, visit HumCapital.com.

Pine Labs Private Limited operates a cloud-based unified point-of-sale (POS) platform, primarily serving merchants in India, Southeast Asia, and the Middle East. Founded in 1998 and headquartered in Noida, India, the company provides a range of digital payment acceptance and merchant commerce solutions, including Android-based smart POS devices. Pine Labs offers several features to enhance the merchant experience, such as instant equated monthly installment payment options, loyalty programs, gift cards, and customer analytics. Its myPlutus app provides real-time transaction data, while Promozone facilitates targeted promotional campaigns. The platform supports over 350,000 POS terminals across 3,700 locations, serving more than 100,000 merchants in various sectors, including electronics, food and beverage, and fashion. Additionally, Pine Labs collaborates with financial institutions and brands to create value for retail customers, thereby simplifying payment acceptance and enhancing the overall transaction experience.

Aumni is a data-driven investment management platform based in the United States that serves the venture capital industry. It offers a portfolio intelligence solution that helps venture capital firms enhance their operational efficiency and gain a competitive edge. Aumni's platform audits, analyzes, and visualizes key data from venture capital deal documents, extracting hundreds of data points to track critical insights, including investment rights, portfolio performance, and emerging investment trends. By converting complex deal data into a clear and error-free dataset, Aumni enables investors and venture firms to make informed strategic decisions and streamline their daily operations. The platform is designed for forward-thinking investment teams aiming to unlock and structure the vast amounts of untapped data within their portfolios.

Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

Mynd is a property management platform that simplifies rental management services for property owners. The platform provides real-time insights into rental income, vacancies, and maintenance requests, allowing users to efficiently manage their properties from anywhere. Through its mobile app, Mynd offers up-to-date performance data, enabling landlords to track rent payments, approve expenses, and stay informed about local market trends. The company's focus on leveraging technology and data aims to enhance the overall management experience and maximize returns for property owners. Mynd is headquartered in the East Bay of San Francisco and is dedicated to providing unparalleled service to its clients.

Brii Biosciences is a developer of bio-pharmaceutical medicines intended to provide medical solutions to Chinese patients to fulfill their health and treatment needs. The company's medicines focuses on infectious disease drug development and commercialization in China and leverage technology and data to drive improvements to the Chinese healthcare system and outcomes for patients, enabling patients to get access to better treatments and cures for life-threatening diseases.

Godrej Properties, established in 1990, is the real estate development arm of the Godrej Group, based in Mumbai. The company focuses on developing a diverse range of residential, commercial, and township projects across India, covering an area of 10.3 million square meters in 12 cities. Committed to sustainability, all of its developments are certified green buildings, reflecting a philosophy of innovation and excellence that the Godrej Group has upheld for over 119 years. In addition to real estate, Godrej Properties also manages investments through funds like Godrej Office Fund II, which targets office assets in Mumbai. The firm aims to deliver high-quality and technologically advanced properties, enhancing the living and working environments in urban India.

Nubank issues, administrate, processes, and transfers payments related to post-paid credit cards and equity investment in other entities. It serves clients in Brazil. The company launched its proprietary loyalty rewards program ("Nubank Rewards"), as well as a digital account ("NuConta") that is already used by more than 17 million people. In Cristina Junqueira, David Velez, and Edward Wible founded EO2 Solucoes de Pagamento on May 6, 2013 that became Nubank in on June 25, 2013. It has its headquarters in São Paulo in Brazil.

Expert System provides technology and tools that support the creation, development, implementation and management of AI applications to unlock the value of language in the enterprise at speed and scale. Its flagship platform provides a mix of natural language understanding and machine learning algorithms to help organizations bring humanlike comprehension of any kind of text to accelerate business processes, enhance knowledge discovery and improve decision making. Headquartered in Italy, the company operates throughout Europe, the Americas, Canada and the Middle East across a vast range of sectors and use cases including content enrichment, customer care, compliance, third party risk mitigation and intelligence applications.

Clarksons offers its diverse and growing client base an unrivalled range of shipbroking services, sector research, on-hand logistical support and full investment banking capabilities in all key shipping and offshore sectors.

RedBlack Software, LLC provides technology solutions to investment advisors, wealth managers, broker dealers, and financial institutions. The company offers Rebalance Express, a software application for portfolio monitoring, rebalancing, and trading. Additionally, it provides tools for single and multiple accounts rebalancing, real-time pricing, tax lot management, portfolio and trade management, security and asset class model creation, cash management, and compliance and trade report generation. RedBlack Software, LLC was founded in 2006 and is based in Bedford, New Hampshire.

Grab Holdings Inc. is a Singapore-based company that offers a comprehensive mobile technology platform providing various online-to-offline services in Southeast Asia. Founded in 2012 by Anthony Tan and Tan Hooi Lng, Grab operates in several countries, including Singapore, Indonesia, the Philippines, Malaysia, Thailand, Vietnam, and Myanmar. The platform includes a wide range of services such as transportation options like GrabTaxi and GrabCar, and delivery services, alongside solutions for financial transactions through Grab Financial Group. This group provides services in payments, rewards, lending, and insurance, and features a user-friendly point-of-sale system for merchants, as well as a mobile wallet for convenient transactions. Grab aims to enhance the quality of life for its users by integrating essential services into a single app.

They are dedicated to serving the needs of our clients, who range from financial advisors and individual investors to corporations and endowments.

IntelliFlo Ltd. is a software company based in Kingston-upon-Thames, United Kingdom, established in 2004. It specializes in providing web-based business management solutions tailored for the financial services sector, including financial advisers, mortgage advisers, and various service providers. The company's flagship product, Intelligent Office, offers a comprehensive suite of features such as client management, document management, compliance tools, financial planning, and analytics. Additionally, it includes functionalities for lead management, task management, and income reconciliation, catering to both small and large businesses. IntelliFlo also provides product training services to enhance user proficiency. The company's focus on delivering practical, state-of-the-art software solutions aligns with the evolving needs of its clients in a dynamic market.

Alfred is an end-to-end resident experience and building management platform that is changing the way people live and transforming the real estate industry. Operating at the intersection of real estate and technology, Alfred builds intuitive, personal support into one of the most important spaces of our lives: our homes. Named one of the Top 50 Most Innovative Companies in the World by Fast Company in the urban development space, Alfred has been recognized in The New York Times, The Financial Times, and Wall Street Journal, as a pioneer in the on-demand economy, following their decision to hire Alfred Home Managers as W-2 employees (complete with benefits, training, and the ability to move up in the organization) and its support of local ecosystems and neighborhood businesses. Hello Alfred was founded in 2014 by Marcela Sapone and Jessica Beck, and is headquartered in New York, New York, United States.

Lamellar Biomedical Ltd. operates as a biotechnology company that develops and commercializes a range of medical devices and pharmaceuticals based on mimetics of extra-alveolar lamellar bodies. The company offers Lamellasomes, a synthetic substance that mimics the actions lamellar bodies and provides treatment for respiratory diseases, such as cystic fibrosis. Its products target radiotherapy induced xerostomia, dry eye disease, cystic fibrosis, and infection. Lamellar Biomedical Ltd. was formerly known as Macrocom (964) Limited and changed its name to Lamellar Biomedical Ltd. in February 2007. The company was incorporated in 2006 and is based in Bellshill, United Kingdom.

Source is uniquely positioned to deliver highly liquid products that respond to the challenges and opportunities of the market They partner with some of the world’s largest investment houses and asset managers to create products that either offer exposure to new opportunities in the market or deliver existing strategies more effectively. They work together to ensure all of their products are efficient and transparent. On top of this, they work closely with some of the most well respected trading houses in Europe to ensure that their products are also priced as fairly as possible and are tradable throughout the day. Source is a global investment firm and one of the fastest growing European providers of exchange traded products (ETPs) By focusing on the ever-evolving needs of investors, they have grown assets under management to more than $19 billion (as at 30 July 2014) since their launch in April 2009, and during this time investors have traded more than $575 billion of Source’s products. They offer investors an efficient and transparent way to invest in equities, fixed income and commodities, as well as some alternative asset classes. Their ETPs are open-ended and domiciled in Dublin.

Glide Pharmaceutical Technologies Limited is a clinical-stage development company based in Abingdon, United Kingdom, specializing in solid dose formulations of therapeutics and vaccines. The company has developed the Solid Dose Injector (SDI) system, aimed at enhancing patient compliance for those self-administering long-term therapies. Its product pipeline includes solid dose formulations for medications such as octreotide, teriparatide, and vaccines for anthrax and influenza. Additionally, Glide is working on a novel non-invasive diagnostic technology focusing on prostate cancer, which seeks to identify clinically significant disease through a biochemical marker. Founded in 2001, the company was previously known as Caretek Medical Ltd. before rebranding in 2006.

Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing of rationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily. It was founded in 2010 and is headquartered in Cambridge, Massachusetts.

NEXEON Limited operates as a battery materials and licensing company that develops silicon anodes for lithium-ion batteries. It offers silicon anode technology solutions for various applications, including consumer electronic, electronic vehicle, sustainable energy, aerospace, medical, and defense industries in the United Kingdom and internationally. The company was founded in 2006 and is based in Abingdon, United Kingdom with an additional office in Yokohama, Japan.

Jemstep Inc. offers online investment guidance and management services tailored for individual investors and financial advisors. Founded in 2008 and headquartered in Los Altos, California, the company leverages technology to provide ratings and comprehensive information on mutual funds and ETFs, including performance analysis and asset allocation. Jemstep's platform, Jemstep Advisor Pro, enhances the operations of investment advisors by automating client engagement, onboarding, and service processes, enabling them to attract more clients and manage assets more efficiently. The platform integrates with various service providers, allowing for a customizable business system that supports advisors in delivering enhanced value to their clients.

Gelesis, Inc. is a biotechnology company focused on developing therapies for gastrointestinal-related chronic diseases, particularly obesity and type 2 diabetes. Utilizing a mechanobiology technology platform, Gelesis creates innovative products aimed at weight management. Its lead product, Gelesis100, is an orally administered smart pill composed of hydrogel particles that expand in the gastrointestinal tract, promoting a feeling of fullness and aiding in calorie reduction. This product is designed to be safe, having materials recognized as safe by regulatory authorities. In addition to Gelesis100, the company has a pipeline of potential therapies targeting conditions such as non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic idiopathic constipation. Founded in 2006, Gelesis is based in Boston, Massachusetts.

Lamellar Biomedical Ltd. operates as a biotechnology company that develops and commercializes a range of medical devices and pharmaceuticals based on mimetics of extra-alveolar lamellar bodies. The company offers Lamellasomes, a synthetic substance that mimics the actions lamellar bodies and provides treatment for respiratory diseases, such as cystic fibrosis. Its products target radiotherapy induced xerostomia, dry eye disease, cystic fibrosis, and infection. Lamellar Biomedical Ltd. was formerly known as Macrocom (964) Limited and changed its name to Lamellar Biomedical Ltd. in February 2007. The company was incorporated in 2006 and is based in Bellshill, United Kingdom.

Mereo is based in London and was founded in March 2015 to fund and develop novel, innovative specialist focused products from large pharmaceutical or biotechnology companies. Pharmaceutical companies face increasingly difficult choices in the allocation of internal resources to their drug development programs. With significant P&L constraints and rich pipelines it has become increasingly difficult for many companies to fully fund and advance development all of their drug candidates, especially beyond Phase 2. Mereo has been formed to take advantage of the global pharmaceutical industry's drive for creative ways to progress their clinical development pipelines. Mereo has acquired an initial mid-late stage portfolio of three exceptionally well characterised novel products for the treatment of diseases with considerable unmet medical need from Novartis Pharmaceuticals. Each of these programmes has a comprehensive dataset for both pre-clinical and proof-of-concept clinical studies. Additional product opportunities are under evaluation. Mereo's focus is the development of innovative medicines that have the potential to significantly transform the lives of patients suffering from rare and other specialised conditions around the world. To do this, the Company depends on the combination of its team's expertise in selecting and acquiring product opportunities, creating value in the development pipeline and structuring creative transactions. Mereo's internal expertise is complemented by a unique partnership with a leading global CRO, ICON. Mereo combines the operational discipline and efficiency of a small company with the financial resources to conduct comprehensive clinical studies. Mereo will rapidly progress each of the products through further value inflection points before partnering or divesting its products. The Company also has the option to directly commercialise products, for example in orphan disease indications.

Akamis Bio is a biotechnology company dedicated to developing innovative gene-based immuno-oncology therapies for cancer treatment. The company focuses on discovering and advancing a range of candidate therapies, including those utilizing its proprietary T-SIGn virus platform, which allows for systemic delivery while exerting localized effects within tumors. Akamis Bio aims to become a leader in cancer gene therapy, emphasizing the importance of creating medicines that provide tangible benefits to patients. The company is actively engaged in both early and clinical stage development of its therapies and seeks to establish strategic partnerships with other leaders in the immuno-oncology field to enhance its product offerings and accelerate the availability of its treatments.

SciFluor Life Sciences is an Allied Minds funded company with a late-stage fluorination technology that improves drug properties such as metabolic stability, potency, bioavailability, and blood-brain-barrier penetration. The company's late-stage fluorination technology is licensed exclusively from Harvard University. SciFluor's technology enables end-stage or any-stage fluorination of a wide variety of organic compounds.

Focused on helping the IM community efficiently source block liquidity through transparent trading protocols.

Genomics PLC develops algorithms and software solutions that focus on cancer, microbes, and rare diseases. Its solutions allow governments and healthcare providers to transform healthcare provisions for their citizens and members; pharmaceutical and biotechnology clients to de-risk the drug development process; clinicians and doctors to improve diagnoses and treatment options; and research laboratories and genome analysts to process results accurately. The company was incorporated in 2014 and is based in Oxford, United Kingdom.

Cell Medica is a cell therapy company working on new techniques to cure human diseases based upon a treatment method called cellular immunotherapy. This technique involves harnessing and enhancing the power of the human immune system to fight disease. Based on a number of academic studies, there is strong evidence that cellular immunotherapy can be used in a safe and effective manner to treat diseases ranging from infections to cancer. Cell Medica is both an R&D company developing new forms of cell therapies and a cell production/processing company providing clinical-grade cell formulations to hospitals for the treatment of patients.

Generator Hostel provides owns and operates hostels that provide accommodations (shared to private) for travelers.

Space Exploration Technologies is a space-transportation startup company founded by Elon Musk. SpaceX designs, manufactures, and launches advanced rockets and spacecraft. SpaceX develops crew and cargo capsules, engines, cryogenic tank structures, avionics, equipment, guidance, and control software. The company is developing the partially reusable launch vehicles Falcon 1 and Falcon 9. Founded in 2002, Space Exploration Technologies is headquartered in Hawthorne, California.

Alkermes Pharmaceutical Manufacturing and Global Biopharmaceutical Company

Ensurge Micropower specializes in the design and production of advanced ultrathin energy storage solutions, primarily focusing on solid-state lithium battery technology. This innovative approach allows for the development of rechargeable batteries characterized by high energy densities and extended product life, making them ideal for wearable devices, connected sensors, and various other applications. Founded in 2005 and headquartered in Oslo, Norway, the company leverages its expertise in printed electronics and roll-based manufacturing to create cost-effective solutions. By integrating hardware with smart packaging, Ensurge Micropower aims to advance the Internet of Things, facilitating seamless communication between brands and consumers. The company emphasizes enhancing consumer engagement and brand loyalty through efficient digital marketing strategies, positioning itself as a leader in the field of energy storage and smart technology solutions.

PolyTherics has focused on technology development in the area of biomedical polymers for therapeutic applications. The most advanced of its techniques, site-specific PEGylation or TheraPEG, is being exploited in partnership with companies developing biopharmaceuticals. PolyTherics is also committed to developing its own pipeline of optimised clinical candidates.

infirst Healthcare Ltd. develops cocoa-flavoured medicine for the treatment of cough and cold. The company was incorporated in 2012 and is based in London, United Kingdom.

Xeros Ltd. is a new company focused on the development of "virtually waterless" laundry cleaning. Harnessing over 30 years of research by Professor Stephen Burkinshaw and the University of Leeds, Xeros is the brand name for a patented polymer based cleaning that creates step change advantage in the cost and environmental impact of aqueous wash cleaning.

Glide Pharmaceutical Technologies Limited is a clinical-stage development company based in Abingdon, United Kingdom, specializing in solid dose formulations of therapeutics and vaccines. The company has developed the Solid Dose Injector (SDI) system, aimed at enhancing patient compliance for those self-administering long-term therapies. Its product pipeline includes solid dose formulations for medications such as octreotide, teriparatide, and vaccines for anthrax and influenza. Additionally, Glide is working on a novel non-invasive diagnostic technology focusing on prostate cancer, which seeks to identify clinically significant disease through a biochemical marker. Founded in 2001, the company was previously known as Caretek Medical Ltd. before rebranding in 2006.

Lamellar Biomedical Ltd. operates as a biotechnology company that develops and commercializes a range of medical devices and pharmaceuticals based on mimetics of extra-alveolar lamellar bodies. The company offers Lamellasomes, a synthetic substance that mimics the actions lamellar bodies and provides treatment for respiratory diseases, such as cystic fibrosis. Its products target radiotherapy induced xerostomia, dry eye disease, cystic fibrosis, and infection. Lamellar Biomedical Ltd. was formerly known as Macrocom (964) Limited and changed its name to Lamellar Biomedical Ltd. in February 2007. The company was incorporated in 2006 and is based in Bellshill, United Kingdom.

Cell Medica is a cell therapy company working on new techniques to cure human diseases based upon a treatment method called cellular immunotherapy. This technique involves harnessing and enhancing the power of the human immune system to fight disease. Based on a number of academic studies, there is strong evidence that cellular immunotherapy can be used in a safe and effective manner to treat diseases ranging from infections to cancer. Cell Medica is both an R&D company developing new forms of cell therapies and a cell production/processing company providing clinical-grade cell formulations to hospitals for the treatment of patients.

Akamis Bio is a biotechnology company dedicated to developing innovative gene-based immuno-oncology therapies for cancer treatment. The company focuses on discovering and advancing a range of candidate therapies, including those utilizing its proprietary T-SIGn virus platform, which allows for systemic delivery while exerting localized effects within tumors. Akamis Bio aims to become a leader in cancer gene therapy, emphasizing the importance of creating medicines that provide tangible benefits to patients. The company is actively engaged in both early and clinical stage development of its therapies and seeks to establish strategic partnerships with other leaders in the immuno-oncology field to enhance its product offerings and accelerate the availability of its treatments.

Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).

Oxford Nanopore Technologies Limited specializes in the development and commercialization of nanopore-based electronic systems for the analysis of single molecules, particularly in the fields of DNA and RNA sequencing. The company offers a range of products, including the portable MinION device for molecular analysis, the benchtop PromethION for large-scale sequencing projects, and the GridION system suitable for various molecular sensing applications. Their technology supports diverse scientific research areas such as genomics, cancer studies, microbiology, and environmental research, with applications extending to healthcare, agriculture, and food safety. The Flongle device caters to on-demand sequencing needs, while the MinIT accessory enhances the functionality of their sequencing devices. Oxford Nanopore’s innovative technology emphasizes accessibility and ease of use, with rapid library preparation and automated processes. Founded in 2005 and headquartered in Oxford, United Kingdom, the company operates additional offices worldwide, enabling its products to be utilized in over 80 countries.

Spin Memory, Inc. specializes in developing spin-transfer torque magnetoresistive random access memory (MRAM) technologies and products, addressing the challenges of scaling and power consumption in memory devices. By replacing on-chip SRAM and various non-volatile memories, its solutions cater to both embedded and stand-alone applications. Originally founded in 2007 as Spin Transfer Technologies, the company emerged from a collaboration between Allied Minds and New York University, leveraging technology discovered by Professor Andrew Kent. This innovative orthogonal spin transfer MRAM technology promises significant advancements, including faster switching times, reduced power usage, and greater scalability. Spin Memory is headquartered in Fremont, California.

Centrify redefines security from a legacy static perimeter-based approach to protecting millions of scattered connections in a boundaryless hybrid enterprise. As the only industry-recognized leader in both Privileged Identity Management and Identity-as-a-Service, Centrify provides a single platform to secure each user’s access to apps and infrastructure through the power of identity services. This is Next Dimension Security in the Age of Access. Centrify is enabling over 5,000 customers, including over half the Fortune 50, to defend their organizations. To learn more visit www.centrify.com. The Breach Stops Here.

NEXEON Limited operates as a battery materials and licensing company that develops silicon anodes for lithium-ion batteries. It offers silicon anode technology solutions for various applications, including consumer electronic, electronic vehicle, sustainable energy, aerospace, medical, and defense industries in the United Kingdom and internationally. The company was founded in 2006 and is based in Abingdon, United Kingdom with an additional office in Yokohama, Japan.

Oxford Nanopore Technologies Limited specializes in the development and commercialization of nanopore-based electronic systems for the analysis of single molecules, particularly in the fields of DNA and RNA sequencing. The company offers a range of products, including the portable MinION device for molecular analysis, the benchtop PromethION for large-scale sequencing projects, and the GridION system suitable for various molecular sensing applications. Their technology supports diverse scientific research areas such as genomics, cancer studies, microbiology, and environmental research, with applications extending to healthcare, agriculture, and food safety. The Flongle device caters to on-demand sequencing needs, while the MinIT accessory enhances the functionality of their sequencing devices. Oxford Nanopore’s innovative technology emphasizes accessibility and ease of use, with rapid library preparation and automated processes. Founded in 2005 and headquartered in Oxford, United Kingdom, the company operates additional offices worldwide, enabling its products to be utilized in over 80 countries.

Circassia Group Plc is a specialty pharmaceutical company based in Oxford, United Kingdom, focused on developing and commercializing innovative products for respiratory diseases and allergies. The company operates through three key segments: NIOX, Chronic Obstructive Pulmonary Disease (COPD), and LungFit. Circassia markets NIOX and NIOX VERO, which aid in the diagnosis and management of asthma, and offers Tudorza and Duaklir for COPD treatment. Duaklir combines aclidinium bromide and formoterol fumarate, administered via a breath-actuated inhaler. Additionally, Circassia is developing LungFit, a portable system that generates precise amounts of nitric oxide for therapeutic use. The company sells its products directly in the United States, the United Kingdom, China, Italy, and Germany, while also leveraging partnerships for international distribution. Circassia has a collaboration with AstraZeneca to promote its COPD treatments and holds rights to commercialize LungFit in the United States and China. Founded in 2006, Circassia continues to expand its pipeline, including novel treatments for allergies and COPD.

MaxWest Environmental Systems develops a system with a gasification and heat integration process that converts biosolids into energy.

Akamis Bio is a biotechnology company dedicated to developing innovative gene-based immuno-oncology therapies for cancer treatment. The company focuses on discovering and advancing a range of candidate therapies, including those utilizing its proprietary T-SIGn virus platform, which allows for systemic delivery while exerting localized effects within tumors. Akamis Bio aims to become a leader in cancer gene therapy, emphasizing the importance of creating medicines that provide tangible benefits to patients. The company is actively engaged in both early and clinical stage development of its therapies and seeks to establish strategic partnerships with other leaders in the immuno-oncology field to enhance its product offerings and accelerate the availability of its treatments.

Oxford Nanopore Technologies Limited specializes in the development and commercialization of nanopore-based electronic systems for the analysis of single molecules, particularly in the fields of DNA and RNA sequencing. The company offers a range of products, including the portable MinION device for molecular analysis, the benchtop PromethION for large-scale sequencing projects, and the GridION system suitable for various molecular sensing applications. Their technology supports diverse scientific research areas such as genomics, cancer studies, microbiology, and environmental research, with applications extending to healthcare, agriculture, and food safety. The Flongle device caters to on-demand sequencing needs, while the MinIT accessory enhances the functionality of their sequencing devices. Oxford Nanopore’s innovative technology emphasizes accessibility and ease of use, with rapid library preparation and automated processes. Founded in 2005 and headquartered in Oxford, United Kingdom, the company operates additional offices worldwide, enabling its products to be utilized in over 80 countries.

Circassia Group Plc is a specialty pharmaceutical company based in Oxford, United Kingdom, focused on developing and commercializing innovative products for respiratory diseases and allergies. The company operates through three key segments: NIOX, Chronic Obstructive Pulmonary Disease (COPD), and LungFit. Circassia markets NIOX and NIOX VERO, which aid in the diagnosis and management of asthma, and offers Tudorza and Duaklir for COPD treatment. Duaklir combines aclidinium bromide and formoterol fumarate, administered via a breath-actuated inhaler. Additionally, Circassia is developing LungFit, a portable system that generates precise amounts of nitric oxide for therapeutic use. The company sells its products directly in the United States, the United Kingdom, China, Italy, and Germany, while also leveraging partnerships for international distribution. Circassia has a collaboration with AstraZeneca to promote its COPD treatments and holds rights to commercialize LungFit in the United States and China. Founded in 2006, Circassia continues to expand its pipeline, including novel treatments for allergies and COPD.

Chelsio is a technology company focused on solving high performance networking and storage challenges for virtualized enterprise data centers, cloud service installations, and cluster computing environments. Now shipping its fourth generation protocol acceleration technology, Chelsio is delivering hardware and software solutions including Unified Wire Ethernet network adapter cards, unified storage software, high performance storage gateways, unified management software, bypass cards, and other solutions focused on specialized applications. Chelsio is a privately-held subsystems company headquartered in Sunnyvale, California.

BaroSense is committed to develop and commercialize novel anti-obesity products that provide a meaningful contribution to this leading healthcare problem facing the United States today. BaroSense was conceived in order to create a safe, simple, effective, and minimally invasive alternative to the surgical treatment of obesity - an innovative approach to assist those people who need help beyond traditional diets, and who wish to avoid extensive, irreversible surgery.

LogLogic offers a scalable log and security intelligence platform designed for both enterprise and cloud environments. With a customer base exceeding 1,300, the company enables organizations to collect and analyze vast amounts of data generated by their IT systems, totaling over 1,000 Petabytes. Its solutions cater to Security, IT Operations, and Compliance professionals, providing them with actionable insights to proactively identify issues and make informed decisions while ensuring compliance with various regulations. LogLogic's products facilitate real-time log analysis, enhancing network stability and security by translating raw data into meaningful information that helps administrators understand network activities and respond effectively.

ConSentry Networks is leading the delivery of intelligent control. Customers around the globe have adopted their intelligent control, enabling them to capitalize on today's new business practices including using contractors, outsourcing and offshoring, and more rapidly establishing working partnerships. ConSentry Networks, Inc. was founded in 2003 and is based in Milpitas, California. The company has received funding from Accel Partners, DAG Ventures, INVESCO Private Capital, and Translink Capital.

At NovaSys Health they value your participation as a contracted provider. Roughly 11,000 providers in this region and over 4,300 providers in Arkansas have contracted with NovaSys Health making it one of the largest health plans in Arkansas. They take pride in the relationships that they have cultivated with providers.

$25 million in Series C preferred stock financing. The financing will be used to ramp up operations and prepare for sales and marketing in anticipation of the company commercializing its first product, the Novasys Micro-remodeling™ System. The system, which is designed to treat female stress urinary incontinence (SUI), has received the CE Mark for use in the European Union and is pending FDA marketing clearance for sale in the United States. Novasys Medical Inc is testing a new, non-incisional, transurethral treatment which requires no visualization of the treatment site (neither cystoscopy nor fluoroscopy), being guided by familiar balloon palpation (similar to a Foley catheter). In addition, the Novasys Micro-remodeling™ System incorporates numerous, automatic safety features making the treatment process very easy to learn and use. The treatment does not require general anesthesia and is performed in the outpatient or office setting. Not only is the treatment rapid (less than 10 minutes), but patients immediately return to virtually all activities. As there are no incisions, no wound care or dressing changes are required.

Circassia Group Plc is a specialty pharmaceutical company based in Oxford, United Kingdom, focused on developing and commercializing innovative products for respiratory diseases and allergies. The company operates through three key segments: NIOX, Chronic Obstructive Pulmonary Disease (COPD), and LungFit. Circassia markets NIOX and NIOX VERO, which aid in the diagnosis and management of asthma, and offers Tudorza and Duaklir for COPD treatment. Duaklir combines aclidinium bromide and formoterol fumarate, administered via a breath-actuated inhaler. Additionally, Circassia is developing LungFit, a portable system that generates precise amounts of nitric oxide for therapeutic use. The company sells its products directly in the United States, the United Kingdom, China, Italy, and Germany, while also leveraging partnerships for international distribution. Circassia has a collaboration with AstraZeneca to promote its COPD treatments and holds rights to commercialize LungFit in the United States and China. Founded in 2006, Circassia continues to expand its pipeline, including novel treatments for allergies and COPD.

Chelsio is a technology company focused on solving high performance networking and storage challenges for virtualized enterprise data centers, cloud service installations, and cluster computing environments. Now shipping its fourth generation protocol acceleration technology, Chelsio is delivering hardware and software solutions including Unified Wire Ethernet network adapter cards, unified storage software, high performance storage gateways, unified management software, bypass cards, and other solutions focused on specialized applications. Chelsio is a privately-held subsystems company headquartered in Sunnyvale, California.

POINT Biomedical is a privately held pharmaceutical company, founded to pursue technologies related to imaging and drug delivery. POINT's core technology is based upon an ultrasonically responsive two-layer, biodegradable microsphere or biSphereâ„¢. One of the most important features of this technology is the ability to noninvasively trigger the biSpheres to release their contents at sites within the body using externally generated pulses of ultrasound. From this basic platform, POINT is developing a pipeline of products that leverage the unique properties of the biSphere technology in the areas of imaging and therapeutics. POINT has initially focused development of this platform on the assessment of tissue specific blood flow. The lead product, CARDIOsphereâ„¢, is a pharmaceutical agent that will enable cardiologists to perform myocardial perfusion imaging studies in the office setting using ultrasound rather than more expensive and cumbersome nuclear (or radioisotope) techniques

BaroSense is committed to develop and commercialize novel anti-obesity products that provide a meaningful contribution to this leading healthcare problem facing the United States today. BaroSense was conceived in order to create a safe, simple, effective, and minimally invasive alternative to the surgical treatment of obesity - an innovative approach to assist those people who need help beyond traditional diets, and who wish to avoid extensive, irreversible surgery.

Cast Iron Systems, Inc. specializes in providing software-as-a-service integration appliances tailored for large and midsize companies. The company offers the iA3000 application integration appliance, which delivers network computing solutions and preconfigured options for both enterprise and on-demand applications. These solutions enable users to connect with specific applications and facilitate integration processes, particularly for SAP and Oracle systems. In addition to its hardware and software offerings, Cast Iron Systems provides consulting, technical support, and educational services to enhance user experience and operational efficiency. Founded in 2001 and based in Mountain View, California, the company was previously known as IronHide Corporation.

AccountNow is a financial services company that specializes in providing prepaid card solutions for approximately 40 million consumers in the United States who lack traditional banking relationships or established credit. By offering alternatives to conventional checking accounts, AccountNow enables these individuals to access essential financial and payment systems. The company's offerings include Visa prepaid cards and various bill payment services, all designed to help consumers manage their finances more effectively. AccountNow's prepaid cards are issued by The Bancorp Bank or MetaBank, allowing them to be used wherever Visa or MasterCard is accepted. This positions AccountNow as a valuable resource for those seeking financial services outside of traditional banking.

Antenova, Ltd. specializes in the design and supply of standard and custom antennas and radio frequency antenna modules. Founded in 1999 and headquartered in Stow-cum-Quy, United Kingdom, the company serves a diverse range of applications, including mobile handsets, adapters, portable devices, laptop computers, and various wireless devices. Antenova is recognized as a leading provider of high-performance antennas specifically for wireless machine-to-machine (M2M) and consumer electronic devices. The company has design, sales, and support centers in Taipei, Taiwan; Chicago, Illinois; and Shanghai, China, alongside manufacturing operations located in Taiwan and China.

Centrify redefines security from a legacy static perimeter-based approach to protecting millions of scattered connections in a boundaryless hybrid enterprise. As the only industry-recognized leader in both Privileged Identity Management and Identity-as-a-Service, Centrify provides a single platform to secure each user’s access to apps and infrastructure through the power of identity services. This is Next Dimension Security in the Age of Access. Centrify is enabling over 5,000 customers, including over half the Fortune 50, to defend their organizations. To learn more visit www.centrify.com. The Breach Stops Here.

Based in London, United Kingdom, Celoxica delivers latency market data access and order execution solutions to the advanced trading community. The company’s solutions include a full range of market data feed handlers for the main U.S. and European equities, options, futures exchanges, and FX. With clients that include trading firms who co-locate their strategic applications in high frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing, the company also offers a single access point for brokers and their clients by handling inbound FIX, credit check, and outbound native protocol to the execution venues. Celoxica was founded in 1996.

Cortina Systems is a prominent supplier of intelligent communication solutions, specializing in advanced port processing and connectivity across various market segments, including Core, Metro, Access, and Enterprise. The company focuses on high-speed analog-digital integration, offering a diverse range of products designed to meet customer demands for performance, density, and flexibility. By understanding and anticipating client needs, Cortina Systems aims to facilitate faster time-to-market and enhance revenue opportunities for its customers. Through continuous innovation, the company is committed to developing foundational technologies that support the evolution of new service generations in the communications semiconductor sector.

LipoScience is pioneering a new field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology. Its first proprietary diagnostic test, the NMR LipoProfile® test, measures the number of low density lipoprotein particles (LDL-P) in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. To date, over 8 million NMR LipoProfile tests have been ordered.

ConSentry Networks is leading the delivery of intelligent control. Customers around the globe have adopted their intelligent control, enabling them to capitalize on today's new business practices including using contractors, outsourcing and offshoring, and more rapidly establishing working partnerships. ConSentry Networks, Inc. was founded in 2003 and is based in Milpitas, California. The company has received funding from Accel Partners, DAG Ventures, INVESCO Private Capital, and Translink Capital.

Cast Iron Systems, Inc. specializes in providing software-as-a-service integration appliances tailored for large and midsize companies. The company offers the iA3000 application integration appliance, which delivers network computing solutions and preconfigured options for both enterprise and on-demand applications. These solutions enable users to connect with specific applications and facilitate integration processes, particularly for SAP and Oracle systems. In addition to its hardware and software offerings, Cast Iron Systems provides consulting, technical support, and educational services to enhance user experience and operational efficiency. Founded in 2001 and based in Mountain View, California, the company was previously known as IronHide Corporation.

XENON® is a biopharmaceutical company focused on the development of novel medicines through the application of our proprietary discovery platform, which we refer to as Extreme Genetics. Our product candidates are based on genetic insights derived from our research of families where individuals exhibit severe traits, or phenotypes. We apply our expertise to predict which phenotypes are caused by single-gene defects. By identifying and characterizing the single-gene defects responsible for such severe phenotypes, we gain valuable insights into their function in human biology and their potential as drug targets. Given that these targets are often involved in diseases beyond the rare genetic disorders in which they are first identified, we are developing proprietary product candidates to treat both orphan as well as more prevalent diseases

Touchdown Technologies, Inc. designs, manufactures, and supports MEMS probecards. The company offers ACCU-TORQ probe, a torsional contactor; and GIGA-TORQ probecards for DRAM applications. Its products support the production wafer test needs of semiconductor manufacturers. Touchdown Technologies, Inc. was formerly known as Integrated Micromachines, Inc. The company was founded in 2003 and is based in Baldwin Park, California.

Based in London, United Kingdom, Celoxica delivers latency market data access and order execution solutions to the advanced trading community. The company’s solutions include a full range of market data feed handlers for the main U.S. and European equities, options, futures exchanges, and FX. With clients that include trading firms who co-locate their strategic applications in high frequency trading environments, market making, liquidity provision, algorithmic trading, and smart order routing, the company also offers a single access point for brokers and their clients by handling inbound FIX, credit check, and outbound native protocol to the execution venues. Celoxica was founded in 1996.

Cortina Systems is a prominent supplier of intelligent communication solutions, specializing in advanced port processing and connectivity across various market segments, including Core, Metro, Access, and Enterprise. The company focuses on high-speed analog-digital integration, offering a diverse range of products designed to meet customer demands for performance, density, and flexibility. By understanding and anticipating client needs, Cortina Systems aims to facilitate faster time-to-market and enhance revenue opportunities for its customers. Through continuous innovation, the company is committed to developing foundational technologies that support the evolution of new service generations in the communications semiconductor sector.

Centrify redefines security from a legacy static perimeter-based approach to protecting millions of scattered connections in a boundaryless hybrid enterprise. As the only industry-recognized leader in both Privileged Identity Management and Identity-as-a-Service, Centrify provides a single platform to secure each user’s access to apps and infrastructure through the power of identity services. This is Next Dimension Security in the Age of Access. Centrify is enabling over 5,000 customers, including over half the Fortune 50, to defend their organizations. To learn more visit www.centrify.com. The Breach Stops Here.

ConSentry Networks is leading the delivery of intelligent control. Customers around the globe have adopted their intelligent control, enabling them to capitalize on today's new business practices including using contractors, outsourcing and offshoring, and more rapidly establishing working partnerships. ConSentry Networks, Inc. was founded in 2003 and is based in Milpitas, California. The company has received funding from Accel Partners, DAG Ventures, INVESCO Private Capital, and Translink Capital.

SkyPilot Networks is a prominent provider of carrier-class broadband wireless equipment, specializing in solutions that facilitate cost-effective network services for service providers, municipalities, and public safety agencies. The company offers a patented multi-hop point-to-multipoint architecture that enhances the performance of high-gain directional antennas to improve reach, reduce interference, and optimize spectral efficiency. This technology enables the rapid deployment of various services, including last-mile Internet access, voice over IP, Wi-Fi hotspots, and video surveillance. SkyPilot's product lineup includes the SkyPilot Connector Mini and SkyPilot Connector Pro, which provide economical customer premises equipment for long-range connectivity, along with the SkyPilot EMS, an element management system that aids in the deployment and management of wireless mesh networks. With a proven track record of scalability and reliability, SkyPilot has successfully delivered units to customers in over 50 countries. The company is headquartered in Santa Clara, California.

Arcot Systems, Inc. specializes in authentication and digital signing solutions designed to protect and verify the digital identities of cardholders and merchants. Founded in 1997 and headquartered in Sunnyvale, California, with a technology center in Bangalore, India, the company offers a range of products, including TransFort for Issuers and Merchants, which facilitate secure authentication processes; RiskFort, which addresses real-time fraud prevention; and SignFort, which streamlines document signing and approval. Additional solutions include WebFort and ArcotID for software-based authentication, as well as A-OK On-Demand for enhanced security in authentication. Arcot Systems caters to various sectors, including financial institutions, pharmaceutical companies, and e-commerce platforms, helping them mitigate online fraud and identity theft while ensuring compliance with regulatory standards.

Cast Iron Systems, Inc. specializes in providing software-as-a-service integration appliances tailored for large and midsize companies. The company offers the iA3000 application integration appliance, which delivers network computing solutions and preconfigured options for both enterprise and on-demand applications. These solutions enable users to connect with specific applications and facilitate integration processes, particularly for SAP and Oracle systems. In addition to its hardware and software offerings, Cast Iron Systems provides consulting, technical support, and educational services to enhance user experience and operational efficiency. Founded in 2001 and based in Mountain View, California, the company was previously known as IronHide Corporation.

GENBAND US LLC is a global provider of real-time communications software solutions, catering to service providers, enterprises, and developers worldwide. The company offers a range of products, including telephony application servers that integrate voice, video, instant messaging, and collaboration across various devices and networks. Its offerings encompass intelligent messaging services, unified communications solutions, and cloud-enabled session border controllers that ensure security and interoperability for fixed and mobile networks. Additionally, GENBAND provides media gateways for digital media stream conversion and network functions virtualization solutions. Established in 1999 and headquartered in Frisco, Texas, GENBAND focuses on enhancing and securing communications infrastructure for a diverse clientele. The company operates as a subsidiary of Sonus Networks, Inc. since 2017.

WhereNet Corporation offers wireless solutions for tracking and managing enterprise assets. I WhereNet provides an integrated wireless infrastructure for real-time location, messaging, and telemetry applications, including WhereLAN, a cellular network of locating access points, transmit devices; WhereLAN LOS, a network of tag transmission receivers which perform locations calculations, database functions, and systems management; WhereTag III, a low-powered active radio frequency transmitters associated with an asset; WhereTag IV, an asset tag, which can be configured to match specific location application requirements; WhereCall, a wireless messaging system used for parts replenishment in industrial manufacturing; and WherePort, a magnetic exciter that extends the functionality of WhereTags. The company also offers Visibility Software Server, a set of software development tools for integrating WhereNet, customer, and third-party applications. The company was founded in 1997 and is headquartered in Santa Clara, California. As of January 25, 2007, WhereNet Corporation operates as a subsidiary of Zebra Technologies Corp.

Confluent Photonics Corporation is developing passive and active DWDM optical components for the telecommunications industry based on silicon-on-insulator (SOI) semiconductor fabrication techniques. The use of SOI along with the CMOS fabrication infrastructure developed to process SOI enables cost-effective high volume optical telecom component solutions for the access, metropolitan and long haul telecom markets. The compatibility of Confluent optical designs and manufacturing techniques with CMOS fabrication also provides a pathway for the future integration of optics and electronics on the same telecommunications chip. Current optical telecommunication product technologies and designs result in miniaturized optical lab benches lacking thermal and mechanical robustness. In contrast, Confluent is designing and fabricating Telcordia-compliant optical chip components for the automated manufacture of integrated optical circuits. These components are designed to be insensitive to their environment. Using semiconductor-manufacturing techniques provides built in optical alignment, high volume production and low cost.

LipoScience is pioneering a new field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology. Its first proprietary diagnostic test, the NMR LipoProfile® test, measures the number of low density lipoprotein particles (LDL-P) in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. To date, over 8 million NMR LipoProfile tests have been ordered.

VIEO provides innovative application service level management solutions for ensuring business certainty. These solutions provide end-to-end visibility of Microsoft web-based and Citrix-based application infrastructures and pinpoint resource problems that impact service levels. Using VIEO solutions, IT organizations can improve service delivery while reducing costs and complexity. VIEO's awards include Computerworld's 2004 Innovative Technology Award and InfoWorld's 2004 Systems Management Product of the Year. Led by IT visionary and successful serial entrepreneur Bob Fabbio, VIEO is headquartered in Austin, Texas.

SkyPilot Networks is a prominent provider of carrier-class broadband wireless equipment, specializing in solutions that facilitate cost-effective network services for service providers, municipalities, and public safety agencies. The company offers a patented multi-hop point-to-multipoint architecture that enhances the performance of high-gain directional antennas to improve reach, reduce interference, and optimize spectral efficiency. This technology enables the rapid deployment of various services, including last-mile Internet access, voice over IP, Wi-Fi hotspots, and video surveillance. SkyPilot's product lineup includes the SkyPilot Connector Mini and SkyPilot Connector Pro, which provide economical customer premises equipment for long-range connectivity, along with the SkyPilot EMS, an element management system that aids in the deployment and management of wireless mesh networks. With a proven track record of scalability and reliability, SkyPilot has successfully delivered units to customers in over 50 countries. The company is headquartered in Santa Clara, California.

StarVox products are sold and serviced through major solution providers such as Hewlett Packard as a complete, factory-integrated IP telephony solution for service providers. The HP/StarVox Next Generation Telephony Solution combines StarVox software with HP's Open Call Multi Controller application platforms and Cisco Powered Network equipment, making it a carrier-grade, industry-standard solution that will allow a full range of value-added services and upgrades

2Wire, based in San Jose, California, specializes in providing broadband service products tailored for telecommunications companies. The company develops integrated solutions designed to enhance broadband service and content delivery throughout homes and small offices. Leveraging its expertise in both software and hardware, 2Wire enables users to maximize the advantages of broadband connectivity. Its offerings include residential gateways, multi-service media platforms, intelligent home servers, and remote management systems, all aimed at facilitating a seamless experience for both consumers and service providers. Additionally, 2Wire supports global telecom carriers with platforms that enable the delivery and management of voice, data, and media services, as well as providing customer support through call centers.

GENBAND US LLC is a global provider of real-time communications software solutions, catering to service providers, enterprises, and developers worldwide. The company offers a range of products, including telephony application servers that integrate voice, video, instant messaging, and collaboration across various devices and networks. Its offerings encompass intelligent messaging services, unified communications solutions, and cloud-enabled session border controllers that ensure security and interoperability for fixed and mobile networks. Additionally, GENBAND provides media gateways for digital media stream conversion and network functions virtualization solutions. Established in 1999 and headquartered in Frisco, Texas, GENBAND focuses on enhancing and securing communications infrastructure for a diverse clientele. The company operates as a subsidiary of Sonus Networks, Inc. since 2017.

Ishoni Networks develops broadband engines for residential and business customers.

EndPoints Inc. is a fabless semiconductor company that provides controller chips used in mass-market consumer products that capture and display video and still digital images across the internet and other networks. The company’s products control the operation of inexpensive digital video and still cameras that can connect to the Internet. These controller chips process and communicate the images that are captured and digitized by CMOS image sensor chips and are then sent through one of the company’s interfaces (USB, 1394, Ethernet, etc.) to a PC.

Confluent Photonics Corporation is developing passive and active DWDM optical components for the telecommunications industry based on silicon-on-insulator (SOI) semiconductor fabrication techniques. The use of SOI along with the CMOS fabrication infrastructure developed to process SOI enables cost-effective high volume optical telecom component solutions for the access, metropolitan and long haul telecom markets. The compatibility of Confluent optical designs and manufacturing techniques with CMOS fabrication also provides a pathway for the future integration of optics and electronics on the same telecommunications chip. Current optical telecommunication product technologies and designs result in miniaturized optical lab benches lacking thermal and mechanical robustness. In contrast, Confluent is designing and fabricating Telcordia-compliant optical chip components for the automated manufacture of integrated optical circuits. These components are designed to be insensitive to their environment. Using semiconductor-manufacturing techniques provides built in optical alignment, high volume production and low cost.

Calient provides high-density 3D MEMS (Micro-Electro-Mechanical Systems) optical circuit switching for software-defined networks and data centers. Its optical circuit switching technology is used by service providers, cloud computing, content delivery, and government networks. This offers businesses with adaptive photonic switching systems that enable dynamic optical layer optimization in software-defined networks and data centers. The company’s 3D-MEMS switches enable dynamic optical-layer sharing, optimization, and automation of high-performance test, compute, and network resources in data centers, optical transport networks, and DevOps test automation facilities. Calient Technologies was established in 1999 and is headquartered in Goleta, California.

Oxagen Limited, a biopharmaceutical company, develops and commercializes anti-inflammatory medicines to treat asthma and other chronic allergic conditions. The company offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhinoconjunctivitis. Its drug programs target the CRTH2 receptor that initiates and maintains allergic conditions. The company develops a pipeline of small molecule drugs. It serves customers in the United Kingdom, Russia, CIS countries, and internationally. Oxagen Limited was incorporated in 1996 and is based in London, United Kingdom.

Sigmatel is a semiconductor company specializing in the design, development, and marketing of proprietary mixed-signal integrated circuits (ICs). These ICs combine significant analog circuitry, which is essential for manipulating real-world signals such as sound and light, with digital circuitry that processes data in binary form. By focusing on this integration of analog and digital technologies, Sigmatel aims to deliver innovative solutions tailored to various applications in the semiconductor industry.